<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685734</url>
  </required_header>
  <id_info>
    <org_study_id>2015-13Obs-CHRMT</org_study_id>
    <nct_id>NCT03685734</nct_id>
  </id_info>
  <brief_title>Visual Outcomes Following Descemet Stripping Automated Endothelial Keratoplasty</brief_title>
  <acronym>VO-DSAEK</acronym>
  <official_title>Visual Outcomes Following Descemet Stripping Automated Endothelial Keratoplasty for Corneal Endothelial Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional Metz-Thionville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Régional Metz-Thionville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess objective and subjective visual outcomes achieved by patients with corneal
      endothelial dysfunction who have undergone surgical treatment with Descemet stripping
      automated endothelial keratoplasty (DSAEK).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since 2006, the technique by removing the Descemet membrane from the recipient cornea was
      renamed Descemet stripping automated endothelial keratoplasty (DSAEK). In recent years, DSAEK
      techniques have evolved, favoring increasingly thinner and finer grafts, known as ultrathin
      DSAEK (UT DSAEK), with the aim of obtaining better visual results.

      Endothelial keratoplasty is now the most common surgical procedure used to treat endothelial
      dysfunction. The current study focused on assessing both objective and subjective visual
      quality outcomes following DSAEK.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">January 1, 2016</completion_date>
  <primary_completion_date type="Actual">June 1, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>1 year</time_frame>
    <description>Scored with reference to the logarithm of the minimum angle of resolution (logMAR) and its variation in line gain.</description>
  </primary_outcome>
  <enrollment type="Actual">36</enrollment>
  <condition>Corneal Endothelial Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with corneal endothelial dysfunction underwent DSAEK
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical eligibility for DSAEK

          -  Informed written consent

          -  Successful completion of DSAEK procedure

          -  Postoperative follow-up at least 1 year

          -  Ability to respond to the questionnaire

        Exclusion Criteria:

          -  Patients with clinical edematous cornea

          -  With significant stromal opacity

          -  With major disturbances of ocular surface

          -  Previous corneal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>September 25, 2018</study_first_submitted>
  <study_first_submitted_qc>September 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>September 25, 2018</last_update_submitted>
  <last_update_submitted_qc>September 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DSAEK</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

